Zilucoplan® in Improving Oxygenation, Short-, Longterm Outcome of COVID19 Patients With Acute Hypoxic Respiratory Failure

NCT04382755 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Zilucoplan®
DRUG: Placebo

Sponsor

University Hospital, Ghent

Collaborators

[object Object]